Annual FCF
$13.80 B
+$2.10 B+17.94%
December 31, 2024
Summary
- As of February 24, 2025, NVS annual free cash flow is $13.80 billion, with the most recent change of +$2.10 billion (+17.94%) on December 31, 2024.
- During the last 3 years, NVS annual FCF has risen by +$1.29 billion (+10.31%).
- NVS annual FCF is now at all-time high.
Performance
NVS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
$3.06 B
-$2.42 B-44.20%
December 31, 2024
Summary
- As of February 24, 2025, NVS quarterly free cash flow is $3.06 billion, with the most recent change of -$2.42 billion (-44.20%) on December 31, 2024.
- Over the past year, NVS quarterly FCF has stayed the same.
- NVS quarterly FCF is now -67.90% below its all-time high of $9.54 billion, reached on September 30, 2007.
Performance
NVS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
$13.80 B
+$1.30 B+10.38%
December 31, 2024
Summary
- As of February 24, 2025, NVS TTM free cash flow is $13.80 billion, with the most recent change of +$1.30 billion (+10.38%) on December 31, 2024.
- Over the past year, NVS TTM FCF has stayed the same.
- NVS TTM FCF is now at all-time high.
Performance
NVS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
NVS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.9% | 0.0% | 0.0% |
| 3 y3 years | +10.3% | 0.0% | 0.0% |
| 5 y5 years | +21.4% | 0.0% | 0.0% |
NVS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +17.9% | -44.2% | +287.6% | at high | +34.7% |
| 5 y | 5-year | at high | +24.8% | -44.2% | +287.6% | at high | +34.7% |
| alltime | all time | at high | +363.7% | -67.9% | +148.2% | at high | +1013.6% |
Novartis AG Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $13.80 B(+17.9%) | $3.06 B(-44.2%) | $13.80 B(+10.4%) |
| Sep 2024 | - | $5.49 B(+32.3%) | $12.51 B(+6.8%) |
| Jun 2024 | - | $4.15 B(+273.9%) | $11.71 B(+14.3%) |
| Mar 2024 | - | $1.11 B(-37.1%) | $10.25 B(-12.5%) |
| Dec 2023 | $11.71 B(-2.4%) | $1.76 B(-62.4%) | $11.71 B(-13.6%) |
| Sep 2023 | - | $4.70 B(+75.3%) | $13.55 B(+2.1%) |
| Jun 2023 | - | $2.68 B(+4.3%) | $13.28 B(-3.6%) |
| Mar 2023 | - | $2.57 B(-28.9%) | $13.78 B(+14.8%) |
| Dec 2022 | $12.00 B(-4.1%) | $3.61 B(-18.3%) | $12.00 B(+2.5%) |
| Sep 2022 | - | $4.42 B(+39.4%) | $11.71 B(+0.3%) |
| Jun 2022 | - | $3.17 B(+301.5%) | $11.67 B(-3.0%) |
| Mar 2022 | - | $790.00 M(-76.2%) | $12.03 B(-3.9%) |
| Dec 2021 | $12.52 B(+13.1%) | $3.32 B(-24.3%) | $12.52 B(+2.8%) |
| Sep 2021 | - | $4.39 B(+24.1%) | $12.18 B(+18.0%) |
| Jun 2021 | - | $3.54 B(+177.9%) | $10.32 B(+0.3%) |
| Mar 2021 | - | $1.27 B(-57.3%) | $10.29 B(-7.0%) |
| Dec 2020 | $11.06 B(-2.7%) | $2.98 B(+17.9%) | $11.06 B(+0.7%) |
| Sep 2020 | - | $2.53 B(-27.9%) | $10.99 B(-11.8%) |
| Jun 2020 | - | $3.51 B(+71.6%) | $12.46 B(+7.2%) |
| Mar 2020 | - | $2.04 B(-29.6%) | $11.62 B(+2.2%) |
| Dec 2019 | $11.37 B(-2.2%) | $2.90 B(-27.4%) | $11.37 B(-1.8%) |
| Sep 2019 | - | $4.00 B(+49.8%) | $11.58 B(+7.3%) |
| Jun 2019 | - | $2.67 B(+49.0%) | $10.79 B(-6.8%) |
| Mar 2019 | - | $1.79 B(-42.5%) | $11.58 B(-0.4%) |
| Dec 2018 | $11.62 B(+12.6%) | $3.12 B(-2.9%) | $11.62 B(+2.0%) |
| Sep 2018 | - | $3.21 B(-7.2%) | $11.40 B(+2.6%) |
| Jun 2018 | - | $3.46 B(+88.0%) | $11.11 B(+4.0%) |
| Mar 2018 | - | $1.84 B(-36.3%) | $10.68 B(+3.4%) |
| Dec 2017 | $10.33 B(+20.1%) | $2.89 B(-0.9%) | $10.33 B(+0.8%) |
| Sep 2017 | - | $2.92 B(-3.7%) | $10.25 B(+4.1%) |
| Jun 2017 | - | $3.03 B(+103.2%) | $9.85 B(+6.4%) |
| Mar 2017 | - | $1.49 B(-46.9%) | $9.25 B(+7.7%) |
| Dec 2016 | $8.60 B(+2.4%) | $2.81 B(+11.6%) | $8.60 B(-4.2%) |
| Sep 2016 | - | $2.52 B(+3.3%) | $8.97 B(+1.9%) |
| Jun 2016 | - | $2.44 B(+192.4%) | $8.80 B(+6.9%) |
| Mar 2016 | - | $833.00 M(-73.9%) | $8.24 B(-1.9%) |
| Dec 2015 | $8.39 B(-20.0%) | $3.19 B(+35.9%) | $8.39 B(-12.3%) |
| Sep 2015 | - | $2.35 B(+25.6%) | $9.57 B(-6.5%) |
| Jun 2015 | - | $1.87 B(+88.9%) | $10.24 B(-4.7%) |
| Mar 2015 | - | $989.00 M(-77.4%) | $10.75 B(+2.4%) |
| Dec 2014 | $10.49 B(+7.1%) | $4.37 B(+45.1%) | $10.49 B(+10.5%) |
| Sep 2014 | - | $3.01 B(+26.7%) | $9.50 B(-4.9%) |
| Jun 2014 | - | $2.38 B(+224.4%) | $9.98 B(+6.8%) |
| Mar 2014 | - | $733.00 M(-78.3%) | $9.35 B(-4.5%) |
| Dec 2013 | $9.80 B | $3.37 B(-3.6%) | $9.80 B(-5.5%) |
| Sep 2013 | - | $3.50 B(+100.7%) | $10.37 B(+1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2013 | - | $1.74 B(+48.0%) | $10.18 B(-4.9%) |
| Mar 2013 | - | $1.18 B(-70.2%) | $10.71 B(-6.3%) |
| Dec 2012 | $11.42 B(-4.2%) | $3.95 B(+19.2%) | $11.42 B(-0.9%) |
| Sep 2012 | - | $3.31 B(+45.8%) | $11.52 B(-2.9%) |
| Jun 2012 | - | $2.27 B(+20.0%) | $11.86 B(-4.4%) |
| Mar 2012 | - | $1.89 B(-53.3%) | $12.41 B(+4.1%) |
| Dec 2011 | $11.92 B(+0.7%) | $4.05 B(+10.9%) | $11.92 B(+1.8%) |
| Sep 2011 | - | $3.65 B(+29.3%) | $11.71 B(+7.5%) |
| Jun 2011 | - | $2.82 B(+101.4%) | $10.89 B(+5.0%) |
| Mar 2011 | - | $1.40 B(-63.4%) | $10.38 B(-12.3%) |
| Dec 2010 | $11.84 B(+25.1%) | $3.83 B(+35.2%) | $11.84 B(+3.1%) |
| Sep 2010 | - | $2.83 B(+22.8%) | $11.47 B(+1.7%) |
| Jun 2010 | - | $2.31 B(-19.3%) | $11.28 B(+3.8%) |
| Mar 2010 | - | $2.86 B(-17.7%) | $10.87 B(+14.9%) |
| Dec 2009 | $9.46 B(+26.9%) | $3.47 B(+31.6%) | $9.46 B(+10.0%) |
| Sep 2009 | - | $2.64 B(+38.9%) | $8.60 B(+2.4%) |
| Jun 2009 | - | $1.90 B(+31.1%) | $8.39 B(+10.9%) |
| Mar 2009 | - | $1.45 B(-44.5%) | $7.57 B(+1.5%) |
| Dec 2008 | $7.45 B(+22.6%) | $2.61 B(+7.1%) | $7.45 B(-593.2%) |
| Sep 2008 | - | $2.44 B(+127.5%) | -$1.51 B(-127.0%) |
| Jun 2008 | - | $1.07 B(-19.9%) | $5.59 B(-3.5%) |
| Mar 2008 | - | $1.34 B(-121.0%) | $5.80 B(-4.6%) |
| Dec 2007 | $6.08 B(+0.0%) | -$6.36 B(-166.6%) | $6.08 B(-53.9%) |
| Sep 2007 | - | $9.54 B(+648.8%) | $13.19 B(+134.1%) |
| Jun 2007 | - | $1.27 B(-21.3%) | $5.63 B(-0.2%) |
| Mar 2007 | - | $1.62 B(+114.9%) | $5.64 B(-7.1%) |
| Dec 2006 | $6.07 B(-4.6%) | $753.00 M(-62.1%) | $6.07 B(-8.6%) |
| Sep 2006 | - | $1.99 B(+54.9%) | $6.65 B(-3.8%) |
| Jun 2006 | - | $1.28 B(-37.4%) | $6.91 B(+3.3%) |
| Mar 2006 | - | $2.05 B(+54.7%) | $6.68 B(+4.9%) |
| Dec 2005 | $6.37 B(+24.3%) | $1.32 B(-41.1%) | $6.37 B(+3.0%) |
| Sep 2005 | - | $2.25 B(+111.7%) | $6.19 B(+8.9%) |
| Jun 2005 | - | $1.06 B(-38.8%) | $5.68 B(-4.7%) |
| Mar 2005 | - | $1.74 B(+51.9%) | $5.96 B(+16.2%) |
| Dec 2004 | $5.13 B(+2.3%) | $1.14 B(-34.4%) | $5.13 B(+1.4%) |
| Sep 2004 | - | $1.74 B(+29.9%) | $5.05 B(+3.5%) |
| Jun 2004 | - | $1.34 B(+48.4%) | $4.88 B(+11.6%) |
| Mar 2004 | - | $903.00 M(-15.5%) | $4.37 B(-12.7%) |
| Dec 2003 | $5.01 B(+23.1%) | $1.07 B(-31.8%) | $5.01 B(+27.1%) |
| Sep 2003 | - | $1.57 B(+87.9%) | $3.94 B(+66.0%) |
| Jun 2003 | - | $834.00 M(-45.8%) | $2.37 B(+54.2%) |
| Mar 2003 | - | $1.54 B | $1.54 B |
| Dec 2002 | $4.07 B(+36.7%) | - | - |
| Dec 2001 | $2.98 B(-23.2%) | - | - |
| Dec 2000 | $3.88 B(+11.9%) | - | - |
| Dec 1999 | $3.47 B(+11.6%) | - | - |
| Dec 1998 | $3.11 B | - | - |
FAQ
- What is Novartis AG annual free cash flow?
- What is the all time high annual FCF for Novartis AG?
- What is Novartis AG annual FCF year-on-year change?
- What is Novartis AG quarterly free cash flow?
- What is the all time high quarterly FCF for Novartis AG?
- What is Novartis AG quarterly FCF year-on-year change?
- What is Novartis AG TTM free cash flow?
- What is the all time high TTM FCF for Novartis AG?
- What is Novartis AG TTM FCF year-on-year change?
What is Novartis AG annual free cash flow?
The current annual FCF of NVS is $13.80 B
What is the all time high annual FCF for Novartis AG?
Novartis AG all-time high annual free cash flow is $13.80 B
What is Novartis AG annual FCF year-on-year change?
Over the past year, NVS annual free cash flow has changed by +$2.10 B (+17.94%)
What is Novartis AG quarterly free cash flow?
The current quarterly FCF of NVS is $3.06 B
What is the all time high quarterly FCF for Novartis AG?
Novartis AG all-time high quarterly free cash flow is $9.54 B
What is Novartis AG quarterly FCF year-on-year change?
Over the past year, NVS quarterly free cash flow has changed by $0.00 (0.00%)
What is Novartis AG TTM free cash flow?
The current TTM FCF of NVS is $13.80 B
What is the all time high TTM FCF for Novartis AG?
Novartis AG all-time high TTM free cash flow is $13.80 B
What is Novartis AG TTM FCF year-on-year change?
Over the past year, NVS TTM free cash flow has changed by $0.00 (0.00%)